Identification and external validation of clinical-molecular features to predict benefit from oxaliplatin reintroduction/rechallenge in patients with refractory metastatic colorectal cancer (mCRC)
Salva, F., Paes, R., Silva, M. C. E., Cruz, H., Gonzalez, N. S., Baraibar, I., . . . Tabernero, J., … Read More
